Enanta Pharmaceuticals, Inc.
USD14.51
-0.00 (-0.02%)
CEO
Jay R. Luly
IPO Date
2013-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.53
Prev. Close
$14.51
Day Low
$14.51
Day High
$14.57
52W Low
$6.43
52W High
$17.15
Market Cap
$0.34B
Volume
0.00M
| -1.9 |
| 30 Sept 2023 | FY | 100.0% | -169.0% | -61.7% | -28.9% | 0.12 | 6.73 | -1.8 |
| 30 Sept 2022 | FY | 100.0% | -141.3% | -37.9% | -32.0% | 0.08 | 10.45 | -8.8 |
| 30 Sept 2021 | FY | 100.0% | -81.4% | -19.8% | -17.9% | 0.02 | 8.82 | -14.5 |
| 30 Sept 2020 | FY | 100.0% | -29.5% | -7.9% | -7.4% | 0.02 | 18.08 | -25.2 |
| 30 Sept 2019 | FY | 100.0% | 22.6% | 10.0% | 9.5% | 0.00 | 17.77 | 25.4 |
| 30 Sept 2018 | FY | 100.0% | 34.8% | 18.3% | 17.4% | 0.00 | 23.74 | 24.1 |
| 30 Sept 2017 | FY | 100.0% | 17.2% | 5.9% | 5.4% | 0.00 | 11.33 | 50.4 |
| 30 Sept 2016 | FY | 100.0% | 24.5% | 8.0% | 7.7% | 0.00 | 29.43 | 23.2 |
| -7.1 |
| 30 Sept 2025 | Q4 | 100.0% | -123.6% | -28.9% | -6.7% | 3.11 | 4.21 | -3.4 |
| 30 Jun 2025 | Q3 | 100.0% | -99.7% | -23.0% | -6.1% | 2.61 | 5.00 | -2.2 |
| 31 Mar 2025 | Q2 | 100.0% | -151.7% | -24.2% | -7.0% | 2.31 | 5.29 | -1.3 |
| 31 Dec 2024 | Q1 | 100.0% | -131.4% | -19.9% | -6.4% | 1.98 | 5.47 | -1.4 |
| 30 Sept 2024 | Q4 | 100.0% | -197.3% | -22.4% | -7.7% | 1.75 | 5.21 | -1.9 |
| 30 Jun 2024 | Q3 | 100.0% | -126.1% | -15.2% | -5.7% | 1.52 | 4.92 | -3.1 |
| 31 Mar 2024 | Q2 | 100.0% | -182.7% | -18.8% | -7.5% | 1.38 | 6.43 | -2.9 |
| 31 Dec 2023 | Q1 | 100.0% | -185.6% | -17.4% | -7.8% | 1.15 | 6.25 | -1.5 |